110 results
Page 2 of 6
8-K
EX-99.1
f5z2naao8ano3
4 May 23
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
EX-99.1
t76n2p3y1nre3
3 Apr 23
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
7:05am
8-K
EX-99.1
lido5 r657llvz3wk78o
8 Nov 22
Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update
7:07am
8-K
EX-99.1
fj54i cy6z
3 Nov 22
Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:08am
8-K
EX-99.1
qy4mefrhxe4uyv vlw
7 Sep 22
Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors
7:03am
8-K
EX-99.1
zn6z7ikfmj7izfqa4r
4 Aug 22
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
ml5p4b go6
12 Jul 22
Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration
4:00pm
8-K
EX-99.1
ktnwabshtopayoq3
5 May 22
Bicycle Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:06am
8-K
EX-99.1
dcb89i3x
12 Apr 22
Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
4:14pm
8-K
EX-99.2
b5dowm684ff iu069bj
12 Apr 22
Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
4:14pm